Oncology CRO: Oncology and Hematology Expertise

WE PRIORITIZE TIMELY RESOLUTION OF YOUR QUERIES WITH PROFESSIONAL COMMITMENT.

The majority of clinical trials are in the fields of oncology and hematology, however obtaining regulatory permission is a difficult and risky process. And the search for solutions is urgent for the millions of individuals who receive a cancer diagnosis every year.

Although developments in clinical research in oncology and hematology give patients optimism, they can also pose difficulties for medication developers, such as:

  • The intricacy of creative trial designs and proficient processes
  • Enrollment obstacles that impede the goals of diversity and inclusion
  • Fierce rivalry for patients and suitable locations
  • Greater volume and requirements for data collecting than in other therapeutic fields
  • Rapidly evolving therapeutic approaches and standards of treatment
  • Payor and regulatory requirements that call for ongoing monitoring

Many Studies

Diversity of Patients

Multiple sites

Around the Globe

ADVANCE YOUR CLINICAL RESEARCH WITH A FULL SPECTRUM OF END-TO-
END ONCOLOGY SOLUTIONS

Our innovative approaches and state-of-the-art technology enable our committed staff to generate reliable and strong outcomes with the least amount of inconvenience to patients and trial participants. We provide a whole range of end-to-end solutions, such as utilising adaptive trial design strategies and modifying control arms in the middle as required by preliminary results.

We provide medication developers of all sizes with a comprehensive range of end-to-end solutions so they can:

  • Utilize adaptive trial designs that make use of cutting-edge methods for gathering data and performing statistical analyses.
  • Flex midstream in reaction to preliminary results by changing control arms or increasing the number of arms.
  • Increase the number of patients by utilizing biomarker-driven randomization to focus on those who are most likely to react.
  • Based on the stage of clinical development, patient population, competition, local and national standards of care, regulatory environment, and protocol complexity, choose an appropriate country mix.

EXPLORE OUR END-TO-END ONCOLOGY CAPABILITIES

Functional Service Partnership (FSP) Solutions

Access a wide range of reliable and customizable resources to support key functional areas, fill gaps in internal capabilities or enhance functional expertise.

Contract Development and Manufacturing Organization (CDMO)

Move your molecule to a medicine with an experienced, reliable CDMO partner that offers proven processes for large and small molecules

Laboratory Services

World-class scientific expertise and industry-leading technologies provide comprehensive, fast and accurate lab services

Clinical Trial Design and Management

Leverage a team of oncology experts to build or optimize planning and design scenarios and recruit patients and support sites

Real-World Data and Studies

Dedicated peri- and post-approval services that translate favorable pre-approval clinical trial results into real-world success

Oncology and Hematology in KLCRO

Within the field of oncology, our CRO is proficient in managing clinical trials involving a broad range of cancer types, including hematologic malignancies and solid tumors. We employ state-of-the-art techniques and our wealth of knowledge to investigate new therapy modalities, such as immunotherapies, combination regimens, and targeted medicines. Our dedication to patient-centered care guarantees that cancer trial participants get the best care possible at every stage of their journey.

ONCOLOGY AND HEMATOLOGY LABORATORY SERVICES

KLCRO Laboratory services provide the high-quality data required for prompt, precise decision-making at every stage. Our portfolio in hematology/oncology includes:

Antibody-drug conjugates (ADCs)

Biologics

Biomarkers

Companion diagnostics

Small molecules

KNOW MORE ABOUT OUR THERAPEUTIC LEADERS IN ONCOLOGY AND HEMATOLOGY

KLCRO offers a comprehensive set of clinical research services including pharmaceuticals, alternative medicines, Biotechnological products, and medical devices.

Facebook Instagram Linkedin Youtube
Company
Support
Contact Info
Copyright © 2023 KLCRO, All rights reserved.